Vanda Pharmaceuticals's three largest insider shareholders as of May 30, 2026 are Mihael Hristos Polymeropoulos (President And Ceo, 2.70Mn shares), Gunther Birznieks (Svp, Business Development, 494.20K shares), Kevin Patrick Moran (Svp, Cfo Treasurer, 411.38K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Richard W Dugan | - | 177,454 | 0 | 09 Jun, 2025 |
| Thomas Watkins | - | 63,064 | 0 | 03 Jun, 2022 |
| Mihael Hristos Polymeropoulos | President And Ceo | 2,704,496 | 0 | 04 Mar, 2026 |
| Gunther Birznieks | Svp, Business Development | 494,197 | 0 | 04 Mar, 2026 |
| Timothy Williams | Svp General Counsel | 377,450 | 0 | 04 Mar, 2026 |
| Phaedra Chrousos | - | 123,350 | 0 | 09 Jun, 2025 |
| Joakim Wijkstrom | Svp, Chief Marketing Officer | 333,469 | 0 | 04 Mar, 2026 |
| Aranthan Ii Jones | Chief Corp. Affairs Officer | 81,980 | 0 | 17 Sep, 2021 |
| Anne Sempowski Ward | - | 119,067 | 0 | 09 Jun, 2025 |
| Stephen Ray Mitchell | - | 97,082 | 0 | 16 Jun, 2025 |
| Kevin Patrick Moran | Svp, Cfo Treasurer | 411,380 | 0 | 04 Mar, 2026 |
| Tage Honore | - | 93,469 | 0 | 24 Feb, 2026 |
| Charles Cliff Duncan | - | 57,101 | 0 | 24 Apr, 2026 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 22 Apr, 2026 | Charles Cliff Duncan | Common Stock | A | 57,101 | $0.00 | 57,101 | D | A |
| 02 Mar, 2026 | Timothy Williams | Common Stock | D | 42,434 | $8.27 | 377,450 | D | S |
| 02 Mar, 2026 | Gunther Birznieks | Common Stock | D | 42,431 | $8.27 | 494,197 | D | S |
| 02 Mar, 2026 | Timothy Williams | Common Stock | D | 42,434 | $8.27 | 377,450 | D | S |
| 02 Mar, 2026 | Kevin Patrick Moran | Common Stock | D | 42,442 | $8.27 | 411,380 | D | S |
| 02 Mar, 2026 | Mihael Hristos Polymeropoulos | Common Stock | D | 156,235 | $8.17 | 2,704,496 | D | S |
| 02 Mar, 2026 | Joakim Wijkstrom | Common Stock | D | 30,800 | $8.27 | 333,469 | D | S |
| 02 Mar, 2026 | Timothy Williams | Common Stock | D | 42,434 | $8.27 | 377,450 | D | S |
| 02 Mar, 2026 | Joakim Wijkstrom | Common Stock | D | 30,800 | $8.27 | 333,469 | D | S |
| 02 Mar, 2026 | Joakim Wijkstrom | Common Stock | D | 30,800 | $8.27 | 333,469 | D | S |
| 23 Feb, 2026 | Tage Honore | Common Stock | D | 30,000 | $8.03 | 93,469 | D | S |
| 18 Feb, 2026 | Gunther Birznieks | Common Stock | A | 125,000 | $0.00 | 536,628 | D | A |
| 18 Feb, 2026 | Joakim Wijkstrom | Common Stock | A | 125,000 | $0.00 | 364,269 | D | A |
| 18 Feb, 2026 | Mihael Hristos Polymeropoulos | Common Stock | A | 525,000 | $0.00 | 2,860,731 | D | A |
| 18 Feb, 2026 | Timothy Williams | Common Stock | A | 125,000 | $0.00 | 419,884 | D | A |
| 18 Feb, 2026 | Joakim Wijkstrom | Common Stock | A | 125,000 | $0.00 | 364,269 | D | A |
| 18 Feb, 2026 | Timothy Williams | Common Stock | A | 125,000 | $0.00 | 419,884 | D | A |
| 18 Feb, 2026 | Joakim Wijkstrom | Common Stock | A | 125,000 | $0.00 | 364,269 | D | A |
| 18 Feb, 2026 | Timothy Williams | Common Stock | A | 125,000 | $0.00 | 419,884 | D | A |
| 18 Feb, 2026 | Kevin Patrick Moran | Common Stock | A | 125,000 | $0.00 | 453,822 | D | A |